Menu Expand
Muller's Imaging of the Chest E-Book

Muller's Imaging of the Chest E-Book

Christopher M. Walker | Jonathan H. Chung

(2018)

Additional Information

Book Details

Abstract

Reflecting recent major advances in the field, Müller's Imaging of the Chest, 2nd Edition, by Drs. Christopher M. Walker and Jonathan H. Chung, remains your go-to reference for all aspects of chest radiology, including the latest diagnostic modalities and interventional techniques. This exhaustive resource begins with a review of normal anatomy, progressing to expert coverage based first on how patients present in clinical practice, then on diagnosis or diagnostic category. This practical, easy-to-use format helps you effectively select and interpret the best imaging studies for the everyday challenges you face in thoracic imaging.

  • Provides extensive new information on lung cancer screening, detailing the technique required to perform a lung cancer screening CT as well as how to interpret these examinations using ACR Lung-RADS.
  • Contains four all-new chapters: Idiopathic pleuroparenchymal fibroelastosis, Interstitial pneumonia with autoimmune features, Non-infectious complications of lung and stem cell transplantation, and Leukemia.
  • Updates you on recent advances regarding interstitial lung disease diagnosis, diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH), interstitial pneumonia with autoimmune features (IPAF), pleuroparenchymal fibroelastosis, and much more.
  • Explains the recent CT classification in usual interstitial pneumonia/idiopathic pulmonary fibrosis (UIP/IPF) diagnosis and what features are required to correctly categorize a CT into one of four specific patterns.
  • Covers current topics such as bacterial, viral, fungal, and parasitic infections, and new staging and histologic classifications for various lung neoplasms including lung cancer and mesothelioma.
  • Features more than 3,100 superior, large digital-quality images (many in full color) depicting all of the chest imaging findings you’re likely to see, and helping you distinguish between conditions with similar manifestations.
  • Provides boxes highlighting key points to assist you with report writing, as well as suggestions for treatment and future imaging studies.
  • Features a full-color design throughout, color-coded tables, classic signs boxes, and bulleted lists that highlight key concepts and get you to the information you need quickly.

Table of Contents

Section Title Page Action Price
Front Cover cover
Inside Front Cover ifc1
Muller's Imaging of the Chest i
Copyright Page iv
Dedication v
Contributors vi
Foreword ix
Preface x
Table Of Contents xi
Second half title page xv
1 Normal Chest 1
1 Normal Chest Radiography and Computed Tomography* 1
Radiography 1
Technique 1
Projections 1
Basic Radiographic Techniques 1
Patient Positioning and Respiration 1
Exposure 1
Kilovoltage 1
Image Acquisition 1
Computed Radiography 1
Digital Radiography 2
Normal Anatomy of the Chest 2
Airways 2
Trachea and Bronchi 2
Pulmonary Arterial and Venous Circulation 3
Pulmonary Arteries 3
Pulmonary Veins 6
Pulmonary Hila 6
Lung Parenchyma 9
Secondary Lobule 9
Segments and Lobes 9
Radiographic Density 9
Pulmonary Markings 9
Pleura 9
Interlobar Fissures 9
Accessory Fissures 10
Azygos Fissure. 10
Inferior Accessory Fissure. 10
Superior Accessory Fissure. 10
Left Minor Fissure. 10
Pulmonary Ligament 10
Thoracic Inlet 12
Mediastinum 12
Anatomy 12
Frontal Chest Radiograph 14
Lateral Chest Radiograph 17
Heart 17
Diaphragm 18
Chest Wall 19
Computed Tomography 19
Technical Aspects 19
Incremental and Continuous Volume (Spiral) Computed Tomography 20
Imaging Parameters 23
High-Resolution Computed Tomography 27
Radiation Dose 28
Normal Anatomy 28
Airways 28
Trachea and Main Bronchi 28
Lobar Bronchi and Bronchopulmonary Segments 29
Normal Bronchi on Computed Tomography 29
Bronchioles 37
Pulmonary Arterial and Venous Circulation 37
Pulmonary Arteries 37
Pulmonary Veins 38
Bronchial Circulation 38
Lung Parenchyma 38
Secondary Pulmonary Lobule 38
Acinus 42
Lung Density on Computed Tomography 42
Pleura 42
Anatomy 42
Interlobar Fissures 43
Accessory Fissures 43
Azygos Fissure. 43
Inferior Accessory Fissure. 43
Superior Accessory Fissure. 43
Pulmonary Ligament 43
Mediastinum 44
Supraaortic Region 44
Aortic Arch to Tracheal Carina 46
Subcarinal Region 48
Lymphatic System of the Lungs, Pleura, and Mediastinum 48
Thoracic Duct and Right Lymphatic Duct 49
Lymph Nodes. 49
Parietal and Visceral Groups of Thoracic Lymph Nodes. 49
Lymph Node Size. 49
Diaphragm. 54
Chest Wall. 54
Suggested Readings 56
References 56.e1
2 Radiologic Manifestations of Lung Disease 57
2 Consolidation* 57
Chest Radiograph 57
Silhouette Sign 57
Focal and Multifocal Consolidation 57
Extensive Confluent and Diffuse Consolidation 62
Computed Tomography 65
Acute Causes of Parenchymal Consolidation 66
Pneumonia 66
Pulmonary Edema and Acute Respiratory Distress Syndrome 67
Diffuse Pulmonary Hemorrhage 67
Chronic Causes of Parenchymal Consolidation 68
Organizing Pneumonia 68
Eosinophilic Lung Disease 68
Lipoid Pneumonia 69
Adenocarcinoma 69
Suggested Readings 70
References 70.e1
3 Atelectasis* 71
Mechanisms of Atelectasis 71
Obstructive Atelectasis 71
Passive Atelectasis 71
Compressive Atelectasis 71
Round Atelectasis 71
Adhesive Atelectasis 72
Cicatrization Atelectasis 73
Radiologic Signs of Atelectasis 75
Direct Signs 75
Displacement of Interlobar Fissures 75
Crowding of Vessels and Bronchi 75
Indirect Signs 75
Patterns of Atelectasis 76
Total Pulmonary Atelectasis 77
Lobar Atelectasis 77
Right Upper Lobe 77
Left Upper Lobe 79
Right Middle Lobe 79
Lower Lobes 79
Combined Lobar Atelectasis 83
Combined Right Middle and Lower Lobe Atelectasis. 83
Combined Right Upper and Middle Lobe Atelectasis. 87
Combined Right Upper and Lower Lobe Atelectasis. 87
Migrating Lobar Atelectasis 87
Segmental Atelectasis 88
Linear (Plate-Like) Atelectasis 90
Suggested Readings 90
References 90.e1
4 Nodules and Masses* 91
Solitary Lung Nodule or Mass 91
Location of the Lesion 91
Imaging Characteristics of Lung Nodules 91
Size 91
Change in Size 91
Attenuation: Calcification 94
Attenuation: Fat Density 96
Attenuation: Water Density 96
Attenuation: Air Bronchogram 96
Attenuation: Bubble Lucencies (Pseudocavitation) 96
Attenuation: Focal Nodular Ground-Glass Opacity 98
Attenuation: Computed Tomography Halo Sign 98
Character of the Nodule-Lung Interface 99
Nodule Enhancement: Computed Tomography 100
Nodule Metabolism: Positron Emission Tomography 100
Solitary Pulmonary Mass 100
Algorithm for Evaluation of Pulmonary Nodules 103
Multiple Lung Nodules and Masses 104
Suggested Readings 108
References 108.e1
5 Interstitial Patterns* 109
Septal Pattern 109
Reticular Pattern 109
Cystic Pattern 117
Nodular Pattern 124
Perilymphatic Nodular Pattern 124
Centrilobular Nodular Pattern 126
Tree-in-Bud Pattern 130
Random Distribution 132
Ground-Glass Pattern 132
“Crazy Paving” Pattern 137
Limitations of the Pattern Approach 137
Suggested Readings 137
References 137.e1
6 Decreased Lung Density* 138
Alteration in Pulmonary Volume 138
General Excess of Air 138
Local Excess of Air 139
Bulla 141
Bleb 142
Pneumatocele 142
Alteration in Pulmonary Vasculature 143
Suggested Readings 146
References 146.e1
3 Developmental Lung Disease 147
7 Airway and Parenchymal Anomalies* 147
Anomalous Tracheobronchial Branching 147
Tracheal Bronchus 147
Etiology, Prevalence, and Epidemiology 147
Clinical Presentation 147
Manifestations of the Disease 147
Computed Tomography. 147
Synopsis of Treatment Options 147
Accessory Cardiac Bronchus 147
4 Pulmonary Infection 193
9 Bacterial Pneumonia* 193
Etiology, Prevalence, and Epidemiology 193
Clinical Presentation 193
Pathologic Findings and Pathophysiology 193
Imaging Findings 194
Radiography and Computed Tomography 194
Lobar Pneumonia 195
Bronchopneumonia and Bronchiolitis 195
Hematogenous Spread of Infection 195
Complications 197
Specific Organisms 203
Community-Acquired Pneumonia 203
Streptococcus pneumoniae 203
Haemophilus influenzae 203
Moraxella catarrhalis 203
Atypical Infections 206
Legionella pneumophila 206
Mycoplasma pneumoniae 206
Chlamydia pneumoniae 207
Health Care–Associated, Hospital-Acquired, and Ventilator-Acquired Pneumonia 208
Staphylococcus aureus 208
Pseudomonas aeruginosa 208
Enterobacteriaceae 208
Anaerobic Bacteria 210
Zoonotic Infections 210
Higher-Form Bacteria 212
Nocardia asteroides 212
Actinomyces israelii 212
Imaging Algorithms 212
Differential Diagnosis 214
Synopsis of Treatment Options 214
Suggested Readings 218
References 218.e1
10 Pulmonary Tuberculosis 219
Overview 219
Etiology, Prevalence, and Epidemiology 219
Clinical Presentation 219
Pathologic Findings and Pathophysiology 219
New Concept of Manifestations of the Disease 220
Radiographic Findings 220
Multidetector or High-Resolution Computed Tomography 226
Imaging Algorithm Based on Pros and Cons of Various Modalities 238
Differential Diagnosis 239
Synopsis of Treatment Options 240
Suggested Readings 240
References 240.e1
11 Nontuberculous (Atypical) Mycobacterial Infection* 241
Prevalence and Epidemiology 241
Classification of Nontuberculous Mycobacteria 241
Clinical Presentation: Colonization Versus Infection 241
Pathology 242
Mycobacterium avium-intracellulare Complex 242
Manifestations of Mycobacterium avium-intracellulare Complex Infection 242
Radiography. 242
Computed Tomography. 243
Mycobacterium kansasii 245
Mycobacterium xenopi 246
Mycobacterium malmoense 246
Mycobacterium gordonae 246
Mycobacteria Chelonae and Other Rapidly Growing Nontuberculous Mycobacteria 246
Hot Tub Lung 247
Coexisting Disease and Infection With Nontuberculous Mycobacteria 247
Imaging Algorithm 248
Synopsis of Treatment Options 249
Medical Treatment 249
Surgical Treatment 250
Suggested Readings 250
References 250.e1
12 Fungal Infections 251
Etiology 251
Prevalence and Epidemiology 251
Clinical Presentation 251
Pathophysiology 251
Pathology 251
Manifestations of the Disease 251
Histoplasmosis 251
Acute Histoplasmosis 251
General. 251
Radiography. 251
Computed Tomography. 251
Positron Emission Tomography/Computed Tomography. 252
Imaging Algorithms. 252
Chronic Histoplasmosis 252
General. 252
Radiography. 253
5 Pulmonary Neoplasms 317
16 Screening for Lung Cancer 317
Background 317
Conditions for Screening 317
History of Lung Cancer Screening 317
History of Computed Tomography Screening 317
Screening Programs and Reimbursement 318
Lung Computed Tomography Screening Reporting and Data System (Lung-RADS) 318
Enriching the Screened Population 321
Computer-Aided Detection Assessment of Nodules 321
Biomarkers 322
Conclusion 322
Suggested Readings 323
References 323.e1
17 Lung Cancer 324
Etiology 324
Prevalence and Epidemiology 324
Clinical Presentation 324
Asymptomatic 324
Symptomatic 324
Pathology 325
Lung Function 326
Manifestations of the Disease 327
Radiography 327
Solitary Pulmonary Nodule or Mass 327
Lobar or Segmental Consolidation or Atelectasis 327
Hyperlucent Lung 328
Hilar or Mediastinal Mass 330
Diffuse Interstitial Disease 330
Chest Wall and Lung Apex Involvement 330
Pleural Effusion and Pleural Thickening 330
Computed Tomography 330
Pulmonary Nodule(s) 330
Lobar or Segmental Consolidation or Atelectasis 331
Hilar or Mediastinal Disease 331
Chest Wall and Pleural Involvement 331
Computed Tomography–Guided Biopsy of Intrathoracic Lesions 331
Magnetic Resonance Imaging 332
Ultrasonography 332
Positron Emission Tomography 332
Imaging Algorithms 335
Solitary Pulmonary Nodule 335
Hemoptysis 335
Hilar or Mediastinal Mass on Radiography 335
Lobar Consolidation or Atelectasis 337
Peripheral Lesion 337
Differential Diagnosis 339
Clinical Presentation 339
Hemoptysis 339
Cough 339
Dyspnea 339
Constitutional and Paraneoplastic Symptoms (Fever, Weakness, Weight Loss) 339
Superior Vena Cava Syndrome 339
Vocal Cord Paralysis 339
Horner Syndrome 339
Imaging Findings 340
Solitary Pulmonary Nodule 340
Lobar Consolidation or Atelectasis 340
Mediastinal or Hilar Mass 340
Pleural Effusion 340
Suggested Readings 340
References 340.e1
18 Pulmonary Carcinoma Staging 341
Schemes for Staging 341
Methods of Staging 341
T (Primary Tumor) 341
Radiography 341
Computed Tomography 341
Magnetic Resonance Imaging 342
Positron Emission Tomography 343
N (Lymph Nodes) 343
Radiography and Computed Tomography 343
Magnetic Resonance Imaging 349
Positron Emission Tomography 351
M (Distant Metastases) 353
Conventional Staging 354
Computed Tomography 354
Magnetic Resonance Imaging 354
Bone Scintigraphy 354
Whole-Body Positron Emission Tomography 354
Whole-Body Magnetic Resonance Imaging 354
Whole-Body Positron Emission Tomography–Magnetic Resonance Imaging 354
Adrenal Imaging 354
Staging for Lung Cancers With Multiple Pulmonary Sites of Involvement 361
Tumor-Node-Metastisis Staging for Small Cell Lung Cancer 361
Synopsis of Treatment Options 363
Non–Small Cell Lung Cancer 363
Small Cell Lung Cancer 364
Suggested Readings 364
References 364.e1
19 Neuroendocrine Hyperplasia, Pulmonary Tumorlets, and Carcinoid Tumors* 365
Neuroendocrine Hyperplasia and Pulmonary Tumorlets 365
Etiology, Prevalence, and Epidemiology 365
Clinical Presentation 365
Pathophysiology 365
Imaging Findings 365
Radiography 365
Computed Tomography 365
Differential Diagnosis 366
Synopsis of Treatment Options 366
Typical and Atypical Carcinoid Tumors 367
Etiology, Prevalence, and Epidemiology 367
Clinical Presentation 367
Pathophysiology 367
Imaging Findings 367
Radiography 367
Computed Tomography 369
Magnetic Resonance, Scintigraphy, and Positron Emission Tomography 369
Differential Diagnosis 374
Synopsis of Treatment Options 374
Suggested Readings 375
References 375.e1
20 Pulmonary Hamartoma* 376
Etiology, Prevalence, and Epidemiology 376
Clinical Presentation 376
Pathophysiology 376
Manifestations of the Disease 376
Radiography 376
Computed Tomography 376
Magnetic Resonance Imaging 379
Positron Emission Tomography 379
Imaging Algorithm 379
Differential Diagnosis 379
Synopsis of Treatment Options 380
Suggested Readings 380
References 380.e1
21 Inflammatory Pseudotumor* 381
Etiology, Prevalence, and Epidemiology 381
Clinical Presentation 381
Pathophysiology 381
Manifestations of the Disease 381
Radiography 381
Computed Tomography 381
Magnetic Resonance Imaging 381
Positron Emission Tomography 381
Differential Diagnosis 381
Synopsis of Treatment Options 381
Suggested Readings 383
References 383.e1
22 Pulmonary Metastases* 384
Etiology, Prevalence, and Epidemiology 384
Clinical Presentation 384
Pathophysiology 384
Hematogenous Spread 384
Lymphatic Spread 384
Aerogenous Spread 384
Manifestations of the Disease 384
Radiography 384
Lung Nodules 384
Lymphatic Spread (Lymphangitic Carcinomatosis) 384
Computed Tomography 385
Lung Nodules 385
Lymphatic Spread (Lymphangitic Carcinomatosis) 388
Intravascular Tumor Emboli 388
Bronchial and Tracheal Metastases 389
Magnetic Resonance Imaging 389
Positron Emission Tomography 391
Imaging Algorithms 391
Differential Diagnosis 391
Suggested Readings 392
References 392.e1
6 Lymphoproliferative Disorders and Leukemia 393
23 Pulmonary Lymphoid Hyperplasia and Lymphoid Interstitial Pneumonia (Lymphocytic Interstitial Pneumonia)* 393
Pulmonary Lymphoid Hyperplasia (Follicular Bronchiolitis) 393
7 Diffuse Lung Diseases 429
27 Usual Interstitial Pneumonia/Idiopathic Pulmonary Fibrosis* 429
Etiology, Prevalence, and Epidemiology 429
Clinical Presentation 429
Pathophysiology 429
Pathology 429
Lung Function 430
Manifestations of the Disease 431
Radiography 431
Computed Tomography 432
Differential Diagnosis 437
Synopsis of Treatment Options 438
Suggested Readings 439
References 439.e1
28 Nonspecific Interstitial Pneumonia* 440
Etiology, Prevalence, and Epidemiology 440
Clinical Presentation 440
Pathophysiology 440
Pathology 440
Lung Function 440
Manifestations of the Disease 440
Radiography 440
Computed Tomography 442
Differential Diagnosis 445
Synopsis of Treatment Options 447
Suggested Readings 448
References 448.e1
29 Cryptogenic Organizing Pneumonia/Secondary Organizing Pneumonia* 449
Etiology, Prevalence, and Epidemiology 449
Clinical Presentation 449
Pathophysiology 449
Pathology 449
Lung Function 449
Manifestations of the Disease 449
Radiography 449
Computed Tomography 450
Imaging Algorithms 453
Differential Diagnosis 453
Synopsis of Treatment Options 455
Suggested Readings 455
References 455.e1
30 Acute Interstitial Pneumonia* 456
Prevalence and Epidemiology 456
Clinical Presentation 456
Pathophysiology 456
Pathology 456
Lung Function 456
Manifestations of the Disease 456
Radiography 456
Computed Tomography 456
Imaging Algorithm 456
Differential Diagnosis 460
Synopsis of Treatment Options 460
Suggested Readings 460
References 460.e1
31 Sarcoidosis* 461
Etiology 461
Prevalence and Epidemiology 461
Clinical Presentation 461
Pathophysiology 462
Pathology 462
Lung Function 463
Manifestations of the Disease 463
Radiography 463
Lymph Node Enlargement Without Pulmonary Abnormality 465
Diffuse Pulmonary Disease With or Without Lymph Node Enlargement 465
Nodular Pattern. 465
Reticulonodular Pattern. 465
Parenchymal Consolidation. 465
Fibrosis. 466
Cavitation and Mycetoma Formation. 466
Pleural Disease. 466
Cardiovascular Disease. 466
Computed Tomography 466
Pulmonary Manifestations 466
Pulmonary Arterial Hypertension 474
Hilar and Mediastinal Nodes 474
Cardiac Sarcoidosis 474
Abdominal Manifestations 474
Magnetic Resonance Imaging 475
Gallium-67 Scintigraphy 475
Positron Emission Tomography 476
Diagnostic Algorithm 476
Differential Diagnosis 477
Synopsis of Treatment Options 477
Suggested Readings 477
References 477.e1
32 Hypersensitivity Pneumonitis* 478
Etiology 478
Prevalence and Epidemiology 478
Clinical Presentation 478
Diagnosis 478
Laboratory Findings 479
Lung Function 479
Pathologic Findings 479
Manifestations of the Disease 481
Radiography 481
Computed Tomography 482
Acute Phase 482
Subacute Phase 482
Chronic Phase 489
Acute Exacerbations 491
Differential Diagnosis 492
Synopsis of Treatment Options 493
Suggested Readings 493
References 493.e1
33 Pulmonary Langerhans Cell Histiocytosis* 494
Etiology 494
Prevalence and Epidemiology 494
Clinical Presentation 494
Pathophysiology 494
Pathology 494
Lung Function 495
Manifestations of the Disease 496
Radiography 496
Computed Tomography 496
Positron Emission Tomography 499
Echocardiography 499
Imaging Algorithms 499
Differential Diagnosis 499
Synopsis of Treatment Options 500
Medical 500
Surgical 501
Suggested Readings 501
References 501.e1
34 Smoking-Related Interstitial Lung Disease* 502
Respiratory Bronchiolitis and Respiratory Bronchiolitis–Associated Interstitial Lung Disease 502
Etiology 502
Prevalence and Epidemiology 502
Clinical Presentation 502
Pathophysiology 502
Pathology 502
Lung Function 503
Manifestations of the Disease 503
Radiography 503
Computed Tomography 503
Imaging Algorithms 507
Differential Diagnosis 507
Synopsis of Treatment Options 507
Desquamative Interstitial Pneumonia 507
Etiology 507
Prevalence and Epidemiology 508
Clinical Presentation 508
Pathophysiology 508
Pathology 508
Lung Function 509
Manifestations of the Disease 509
Radiography 509
Computed Tomography 509
Imaging Algorithms 509
Differential Diagnosis 510
Synopsis of Treatment Options 510
Smoking-Related Pulmonary Fibrosis 510
Etiology 510
Usual Interstitial Pneumonia 510
8 Connective Tissue Diseases 552
39 Rheumatoid Arthritis* 552
Etiology 552
Prevalence and Epidemiology 552
Clinical Presentation 552
Pathophysiology 552
Pathology 552
Lung Function 553
Manifestations of the Disease 554
Radiography 554
Computed Tomography 554
Ultrasonography 559
Imaging Algorithms 559
Differential Diagnosis 559
From Clinical Data 559
From Supportive Diagnostic Techniques 559
Synopsis of Treatment Options 559
Suggested Readings 560
References 560.e1
40 Systemic Sclerosis (Scleroderma)* 561
Etiology 561
Prevalence and Epidemiology 561
Clinical Presentation 561
Pathophysiology 562
Pathology 562
Lung Function 562
Manifestations of the Disease 562
Radiography 562
Computed Tomography 562
Differential Diagnosis 564
Treatment 564
Suggested Readings 564
References 564.e1
41 Systemic Lupus Erythematosus* 565
Etiology 565
Prevalence and Epidemiology 565
Clinical Presentation 565
Pathophysiology 566
Pathology 566
Lung Function 566
Manifestations of the Disease 566
Radiography 566
Computed Tomography 566
Nuclear Medicine 568
Imaging Algorithms 569
Differential Diagnosis 569
From Clinical Data 569
From Supportive Diagnostic Techniques 570
Synopsis of Treatment Options 570
Suggested Readings 570
References 570.e1
42 Polymyositis/Dermatomyositis* 571
Etiology 571
Prevalence and Epidemiology 571
Clinical Presentation 571
Pathophysiology 572
Pathology 572
Lung Function 572
Manifestations of the Disease 572
Radiography 572
Computed Tomography 573
Magnetic Resonance Imaging 574
Imaging Algorithms 574
Differential Diagnosis 574
From Clinical Data 574
From Supportive Diagnostic Techniques 575
Synopsis of Treatment Options 575
Suggested Readings 575
References 575.e1
43 Sjögren Syndrome* 576
Etiology 576
Prevalence and Epidemiology 576
Clinical Presentation 576
Pathophysiology 576
Pathology 576
Lung Function 577
Manifestations of the Disease 577
Radiography 577
Computed Tomography 578
Ultrasonography 580
Imaging Algorithms 580
Differential Diagnosis 580
Suggested Readings 580
References 580.e1
44 Mixed Connective Tissue Disease* 581
Etiology 581
Prevalence and Epidemiology 581
Clinical Presentation 581
Pathophysiology 581
Pathology 581
Lung Function 582
Manifestations of the Disease 582
Radiography 582
Computed Tomography 582
Imaging Algorithms 583
Differential Diagnosis 583
From Clinical Data 583
From Supportive Diagnostic Techniques 584
Synopsis of Treatment Options 584
Suggested Readings 584
References 584.e1
45 Interstitial Pneumonia With Autoimmune Features 585
Background 585
Diagnostic Criteria 585
Clinical Features 585
Imaging Features 588
Outcomes and Treatment 589
Suggested Readings 591
References 591.e1
9 Vasculitis and Granulomatosis 592
46 Antineutrophil Cytoplasmic Antibody–Associated Vasculitis* 592
Etiology, Prevalence, and Epidemiology 592
Granulomatosis With Polyangiitis (Formerly Wegener Granulomatosis) 592
Clinical Presentation 592
Pathophysiology 592
Manifestations of the Disease 592
Radiography and Computed Tomography 592
Nuclear Imaging 598
Differential Diagnosis 599
Eosinophilic Granulomatosis With Polyangiitis (Formerly Churg-Strauss Syndrome) 600
Clinical Presentation 600
Pathophysiology 600
Manifestations of the Disease 600
Radiography 600
Computed Tomography 601
Differential Diagnosis 602
Microscopic Polyangiitis 603
Clinical Presentation 603
Pathophysiology 603
Manifestations of the Disease 603
Radiography 603
Computed Tomography 604
Differential Diagnosis 604
Imaging Algorithm 604
Synopsis of Treatment Options 604
Suggested Readings 605
References 605.e1
47 Goodpasture Syndrome (Anti–Basement Membrane Antibody Disease)* 606
Etiology, Prevalence, and Epidemiology 606
Clinical Presentation 606
Pathophysiology 606
Manifestations of the Disease 606
Radiography 606
Computed Tomography 607
Imaging Algorithm 607
Differential Diagnosis 608
Synopsis of Treatment Options 608
Suggested Readings 610
References 610.e1
48 Behçet Disease* 611
Etiology, Prevalence, and Epidemiology 611
Clinical Presentation 611
Pathophysiology 611
Manifestations of the Disease 611
Radiography 611
Computed Tomography 612
Magnetic Resonance Imaging 613
Imaging Algorithm 613
Differential Diagnosis 615
Synopsis of Treatment Options 615
Suggested Readings 615
References 615.e1
49 Takayasu Arteritis* 616
Etiology, Prevalence, and Epidemiology 616
Clinical Presentation 616
Pathophysiology 616
Manifestations of the Disease 617
Radiography 617
Computed Tomography 617
Magnetic Resonance Imaging 619
Angiography 619
Positron Emission Tomography 620
Synopsis of Treatment Options 620
Suggested Readings 621
References 621.e1
10 Pulmonary Embolism, Hypertension, and Edema 622
50 Acute Pulmonary Embolism* 622
Etiology 622
Prevalence and Epidemiology 622
Clinical Presentation 622
Pathology 622
Manifestations of the Disease 622
Radiography 622
Radiographic Features Observed in the Absence of Infarction or Hemorrhage 623
Radiographic Features Suggestive of Infarction or Hemorrhage 624
Additional Findings 624
Computed Tomography 624
Computed Tomography Findings 624
Assessment of Pulmonary Embolism Severity. 625
Standard Multidetector Computed Tomography Protocols. 627
Clinical Validity of a Negative Computed Tomography Pulmonary Angiography 629
Magnetic Resonance Imaging 630
Ultrasonography 630
Nuclear Medicine 630
Differential Diagnosis 632
Pitfalls in the Interpretation of Endoluminal Filling Defects on Computed Tomography Pulmonary Angiography 632
Synopsis of Treatment Options 632
Suggested Readings 632
References 632.e1
51 Chronic Pulmonary Thromboembolism* 633
Etiology 633
Prevalence and Epidemiology 633
Clinical Presentation 633
Pathophysiology 633
Anatomy 633
Pathology 633
Lung Function 635
Manifestations of the Disease 635
Radiography 635
Computed Tomography 635
Cardiovascular Signs of Chronic Pulmonary Thromboembolism 635
Vascular Signs. 635
Pulmonary Hypertension. 637
Systemic Collateral Supply. 638
Cardiac Signs. 638
Parenchymal Signs of Chronic Pulmonary Thromboembolism 638
Mosaic Attenuation. 638
Parenchymal Scarring. 638
Miscellaneous Signs 638
Magnetic Resonance Imaging 638
Ultrasonography 639
Nuclear Medicine 639
Imaging Algorithms 639
Diagnosis and Treatment of Chronic Thromboembolic Pulmonary Hypertension 639
Modalities of Diagnosis. 639
Selection of Surgical Candidates 640
Differential Diagnosis 640
Synopsis of Treatment Options 640
Suggested Readings 641
References 641.e1
52 Nonthrombotic Pulmonary Embolism* 642
Fat Embolism 642
Etiology, Prevalence, and Epidemiology 642
Clinical Presentation 642
Pathophysiology 642
Manifestations of the Disease 642
Radiography 642
Computed Tomography 642
Differential Diagnosis 643
Synopsis of Treatment Options 643
Amniotic Fluid Embolism 644
11 Diseases of the Airways 694
56 Tracheal Diseases* 694
Tracheal Neoplasms 694
Etiology 694
Prevalence and Epidemiology 694
Clinical Presentation 694
Pathophysiology 694
Anatomy 694
Manifestations of the Disease 694
Radiography 694
Computed Tomography 695
Magnetic Resonance Imaging 695
Imaging Algorithms 695
Differential Diagnosis 695
From Clinical Data 695
From Supportive Diagnostic Techniques 697
Types of Tracheal Neoplasms 697
Squamous Cell Carcinoma 697
Adenoid Cystic Carcinoma 698
Mucoepidermoid Carcinoma 698
Tracheal Papilloma 699
Synopsis of Treatment Options 699
Medical 699
Surgical 699
Tracheal Stenosis 699
Etiology 699
Prevalence and Epidemiology 700
Clinical Presentation 701
Pathophysiology 701
Anatomy 701
Pathology 701
Lung Function 701
Manifestations of the Disease 702
Focal Tracheal Narrowing 702
General 702
Radiography 702
Computed Tomography 702
Magnetic Resonance Imaging 702
Imaging Algorithms 702
Differential Diagnosis 702
From Clinical Data 702
From Supportive Diagnostic Techniques 703
Synopsis of Treatment Options 703
Tracheomalacia 703
Etiology 703
Prevalence and Epidemiology 703
Clinical Presentation 703
Pathophysiology 703
Anatomy 703
Pathology 703
Lung Function 703
Manifestations of the Disease 704
General 704
Radiography 704
Computed Tomography 704
Magnetic Resonance Imaging 704
Imaging Algorithms 704
Differential Diagnosis 705
From Clinical Data 705
From Supportive Diagnostic Techniques 705
Synopsis of Treatment Options 705
Medical 705
Surgical 705
Relapsing Polychondritis 705
Etiology 705
Prevalence and Epidemiology 705
Clinical Presentation 705
Pathophysiology 705
Anatomy 705
Pathology 705
Lung Function 706
Manifestations of the Disease 706
Radiography 706
Computed Tomography 706
Magnetic Resonance Imaging 706
Imaging Algorithms 706
Differential Diagnosis 707
From Clinical Data 707
From Supportive Diagnostic Techniques 707
Synopsis of Treatment Options 707
Medical 707
Surgical 707
Tracheomegaly 707
Etiology 707
Prevalence and Epidemiology 708
Clinical Presentation 708
Pathophysiology 708
Anatomy 708
Pathology 708
Lung Function 708
Manifestations of the Disease 708
Radiography 708
Computed Tomography 709
Magnetic Resonance Imaging 709
Imaging Algorithms 709
12 Inhalational Diseases and Aspiration 775
61 Asbestos-Related Disease* 775
Etiology 775
Prevalence and Epidemiology 775
Clinical Presentation 775
Pathophysiology 776
Pathologic Characteristics 776
Asbestos-Related Pulmonary Abnormalities 776
Asbestosis. 776
Rounded Atelectasis. 776
Lung Cancer. 777
Asbestos-Related Pleural Abnormalities 777
Pleural Plaques. 777
Pleural Effusion. 777
Diffuse Pleural Thickening. 777
Mesothelioma. 777
Pulmonary Function Tests 778
Manifestations of the Disease 778
Radiography 778
Interpretation According to the International Classification of Radiographs of the Pneumoconioses 778
Small Rounded Opacities. 778
Small Irregular Opacities. 778
Profusion. 778
Other Findings. 778
Asbestos-Related Pulmonary Abnormalities 778
Asbestosis. 778
Rounded Atelectasis. 779
Asbestos-Related Pleural Abnormalities 779
Pleural Plaques. 779
Diffuse Pleural Thickening. 779
Pleural Effusion. 779
Mesothelioma. 783
Computed Tomography 783
Asbestos-Related Pulmonary Abnormalities 783
Asbestosis. 783
Rounded Atelectasis. 786
Asbestos-Related Pleural Abnormalities 786
Pleural Plaques. 786
Diffuse Pleural Thickening. 788
Pleural Effusion. 789
Mesothelioma. 789
Imaging Algorithms 789
Differential Diagnosis 791
Suggested Readings 792
References 792.e1
62 Silicosis and Coal Workers’ Pneumoconiosis* 793
Etiology 793
Prevalence and Epidemiology 793
Clinical Presentation 794
Silicosis 794
Coal Workers’ Pneumoconiosis 794
Pathophysiology 795
Pathology 795
Silicoproteinosis 795
Accelerated Silicosis 795
Classic (Nodular) Silicosis 795
Progressive Massive Fibrosis 795
Rheumatoid Pneumoconiosis 795
Mixed Dust Fibrosis 796
Coal Workers’ Pneumoconiosis 796
Lung Function 796
Manifestations of the Disease 796
Radiography 796
Silicosis 796
Coal Workers’ Pneumoconiosis 798
Computed Tomography 798
Magnetic Resonance Imaging 805
Positron Emission Tomography/ Computed Tomography 806
Imaging Algorithms 806
Differential Diagnosis 807
Suggested Readings 808
References 808.e1
63 Uncommon Pneumoconioses* 809
Hard Metal Lung Disease 809
Etiology, Prevalence, and Epidemiology 809
Clinical Presentation 809
Pathologic Findings 809
Imaging Findings 809
Radiography 809
Computed Tomography 809
Imaging Algorithm 810
Differential Diagnosis 810
Synopsis of Treatment Options 810
Aluminum Pneumoconiosis (Aluminosis) 812
Etiology, Prevalence, and Epidemiology 812
Clinical Presentation 812
Pathologic Findings 812
Imaging Findings 812
Radiography 812
Computed Tomography 812
Imaging Algorithm 814
Differential Diagnosis 814
Synopsis of Treatment Options 815
Talc Pneumoconiosis 815
Etiology, Prevalence, and Epidemiology 815
Clinical Presentation 815
Pathologic Findings 815
Imaging Findings 815
Radiography 815
Computed Tomography 816
Positron Emission Tomography 817
Imaging Algorithm 817
Differential Diagnosis 817
Synopsis of Treatment Options 817
Welders’ Pneumoconiosis 818
Etiology, Prevalence, and Epidemiology 818
Clinical Presentation 818
Pathologic Findings 818
Imaging Findings 818
Radiography 818
Computed Tomography 818
Imaging Algorithm 818
Differential Diagnosis 818
Chronic Beryllium Disease 820
Etiology, Prevalence, and Epidemiology 820
Clinical Presentation 820
Pathologic Findings 820
Imaging Findings 820
Radiography 820
Computed Tomography 820
Imaging Algorithm 820
Differential Diagnosis 820
Suggested Readings 821
References 821.e1
64 Aspiration 822
Aspiration Pneumonia 822
Etiology, Prevalence, and Epidemiology 822
Clinical Presentation 823
Pathologic Findings and Pathophysiology 823
Manifestations of the Disease 823
Radiography 823
Computed Tomography 824
Differential Diagnosis 824
Aspiration Pneumonitis 825
Etiology, Prevalence, and Epidemiology 825
Clinical Presentation 826
Pathologic Findings 826
Manifestations of the Disease 828
Radiography 828
Computed Tomography 828
Aspiration of Inert and Nontoxic Fluids 828
Aspiration of Water (Drowning) 828
Aspiration of Lipids 830
Etiology, Prevalence, and Epidemiology 830
Clinical Presentation 830
Pathology 830
Manifestations of the Disease 831
Radiography 831
Computed Tomography 831
Aspiration of Foreign Bodies 831
Etiology, Prevalence, and Epidemiology 831
Aspiration Bronchiolitis 833
Gastroesophageal Reflux and Constrictive Bronchiolitis 833
Synopsis of Treatment Options 833
Suggested Readings 835
References 835.e1
13 Iatrogenic Lung Disease and Trauma 836
65 Drug-Induced Lung Disease* 836
Etiology 836
Prevalence and Epidemiology 836
Clinical Presentation and Pathophysiology 836
Choice of Imaging Modality 836
Imaging Patterns 837
Diffuse Alveolar Damage 837
Nonspecific Interstitial Pneumonia 838
Organizing Pneumonia 839
Eosinophilic Pneumonia 842
Hypersensitivity Pneumonitis 842
Diffuse Alveolar Hemorrhage 842
Drugs of Note 842
Illicit Drugs 842
Cocaine. 842
Heroin and Other Opiates. 844
Differential Diagnosis 845
Synopsis of Treatment Options 846
Suggested Readings 846
References 846.e1
66 Therapeutic Radiation and Radiation-Induced Lung Disease* 847
Etiology 847
Prevalence 847
Radiation Therapy Planning and Treatment Terminology 848
Types of Radiation Therapy Delivery 848
Recent Innovations in Radiation Therapy 848
Dose and Fractionation 849
Clinical Presentation 850
Pathophysiology 851
Lung Function 851
Manifestations of the Disease 851
General 851
Radiography 852
Computed Tomography 852
Computed Tomography–Positron Emission Tomography 856
Differential Diagnosis 856
Synopsis of Treatment Options 862
Suggested Readings 862
References 862.e1
67 Blunt Thoracic Trauma* 863
Acute Traumatic Aortic Injury 863
Acute Traumatic Aortic Injury Anatomy 863
Pathology 864
Manifestations of the Disease 864
Radiography 864
Computed Tomography 864
Great Vessel and Supraaortic Branch Vessel Injury 869
Manifestations of the Disease 869
Radiography 869
Computed Tomography 869
Cardiac Injury 869
Pathology 869
Manifestations of the Disease 871
Radiography 871
Computed Tomography 871
Pulmonary Contusion 871
Mechanism of Injury 872
Manifestations of the Disease 872
Radiography 872
Computed Tomography 872
Pulmonary Laceration and Traumatic Lung Cyst 873
Mechanism of Injury 873
Manifestations of the Disease 873
Radiography 873
Computed Tomography 873
Airway Injury 874
14 Pleural Disease 942
71 Pneumothorax 942
Primary Spontaneous Pneumothorax 942
Etiology 942
Prevalence and Epidemiology 942
Familial 942
Pathophysiology 942
Anatomy of the Pleura 943
Clinical Presentation 944
Manifestations of the Disease 945
Radiography 945
Upright Chest Radiograph 945
Supine Chest Radiograph 946
Cause of Pneumothorax on the Chest Radiograph 946
Computed Tomography 946
Ultrasonography 946
Differential Diagnosis 947
Tension Pneumothorax 948
Secondary Pneumothorax 950
Etiology, Prevalence, and Epidemiology 950
Pathophysiology 951
Catamenial Pneumothorax 954
Clinical Presentation 955
Manifestations of the Disease 956
Radiography 956
Computed Tomography 956
Iatrogenic Pneumothorax 957
Bilateral Pneumothorax 959
Pneumothorax Ex vacuo or Trapped Lung 959
Synopsis of Treatment Options 959
Reexpansion Pulmonary Edema 959
Size of Pneumothorax 961
Recurrence of Pneumothorax 961
Hydropneumothorax 961
Suggested Readings 962
References 962.e1
72 Pleural Effusion* 963
Etiology, Prevalence, and Epidemiology 963
Clinical Presentation 963
Manifestations of the Disease 963
Radiography 963
Subpulmonic Effusion 963
Computed Tomography 965
Magnetic Resonance Imaging 967
Ultrasonography 967
Positron Emission Tomography/ Computed Tomography 968
Differential Diagnosis 968
Transudative Effusion 968
Exudative Effusion 968
Infection 968
Malignancy 969
Connective Tissue Diseases and Vasculitis 970
Chylothorax 970
Pleural Effusion Caused by Infection 970
Mycobacteria 970
Epidemiology 970
Pathophysiology 970
Clinical Presentation 970
Manifestations of the Disease 970
Radiography. 970
Computed Tomography. 970
Investigations and Differential Diagnosis 972
Treatment 973
Bacteria Other Than Mycobacteria 973
Prevalence and Epidemiology 973
Bacteriology 973
Clinical Presentation 973
Pathophysiology 973
Manifestations of the Disease 974
Radiography. 974
Computed Tomography. 974
Ultrasonography. 975
Management 975
Fungi 975
Parasites 976
Echinococcus Granulosus 976
Pleural Effusions in Patients With Acquired Immunodeficiency Syndrome 976
Asbestos-Related Pleural Effusion 976
Etiology, Prevalence, and Epidemiology 976
Clinical Presentation 976
Pathophysiology 976
Differential Diagnosis 977
Pleural Effusion Caused by Neoplasms 977
Pulmonary Carcinoma 978
Metastatic Nonpulmonary Carcinoma 978
Hodgkin Disease and Non-Hodgkin Lymphoma 979
Multiple Myeloma 980
Pleural Effusion Caused by Cardiac Failure 980
Pleural Effusion Caused by Pulmonary Thromboembolism 980
Pleural Effusion Caused by Trauma 982
Chylothorax 982
Pleural Effusion in Connective Tissue Disease 983
Pleural Effusion Caused by Immunologic Disease 983
Systemic Lupus Erythematosus 983
Rheumatoid Disease 984
Dressler Syndrome 984
Catamenial Pleural Effusion 985
Pleural Effusion Related to Disease of Abdominal Organs 985
Liver and Biliary Tract 985
Kidney 986
Dialysis 986
Hydronephrosis and Urinoma 986
Nephrotic Syndrome 986
Uremia 986
Pancreas 986
Ovary 986
Ovarian Tumor 986
Ovarian Hyperstimulation Syndrome 986
Subphrenic Abscess 986
Yellow Nail Syndrome 986
Suggested Readings 987
References 987.e1
73 Benign Pleural Thickening 988
Etiology 988
Pathophysiology 988
Anatomy 988
The Apical Cap 988
Pathology 988
Manifestations of the Disease 989
Radiography 989
Computed Tomography 989
Differential Diagnosis 989
Pleural Plaques 989
Etiology, Prevalence, and Epidemiology 989
Clinical Presentation 990
Pathophysiology 991
Pathology 991
Lung Function 991
Manifestations of the Disease 991
Radiography 991
Computed Tomography 993
Magnetic Resonance Imaging 993
Positron Emission Tomography– Computed Tomography 997
Differential Diagnosis 997
Normal Anatomic Structures 997
Talc Pleurodesis 997
Thoracolithiasis and Pleural Fibrin Body 997
Diffuse Pleural Fibrosis 997
Etiology, Prevalence, and Epidemiology 997
Lung Function 999
Pathophysiology 999
Manifestations of the Disease 999
Radiography 999
Computed Tomography 1001
Magnetic Resonance Imaging 1001
Positron Emission Tomography–Computed Tomography 1002
Trapped Lung 1002
Imaging Algorithms 1002
Synopsis of Treatment Options 1006
Surgical 1006
Medical 1006
Differential Diagnosis 1006
Extrapleural Fat 1006
Pleural Fluid 1006
Pleural Plaques 1007
Erdheim-Chester Disease 1007
Diffuse Pulmonary Lymphangiomatosis 1007
Malignant Pleural Disease 1007
Suggested Readings 1007
References 1007.e1
74 Pleural Neoplasms 1008
Malignant Pleural Mesothelioma 1008
Etiology, Prevalence, and Epidemiology 1008
Asbestos 1008
Other Risk Factors 1009
Clinical Presentation 1009
Pathology 1009
Diagnosis 1009
Imaging 1010
General Imaging Features 1010
Radiography 1010
Computed Tomography 1010
Magnetic Resonance Imaging 1011
Fluorodeoxyglucose–Positron Emission Tomography–Computed Tomography 1016
Ultrasonography 1018
Staging 1018
T Classification 1018
N Classification 1019
M Classification 1020
Prognosis 1021
Treatment 1021
Chemotherapy 1021
Surgery 1021
Radiation Therapy 1021
Solitary Fibrous Tumor of the Pleura 1021
Prevalence and Epidemiology 1021
Clinical Presentation 1021
Pathology 1022
Imaging 1022
Radiography 1022
Computed Tomography 1023
Magnetic Resonance Imaging 1023
Ultrasonography 1024
Fluorodeoxyglucose–Positron Emission Tomography–Computed Tomography 1024
Treatment 1025
Miscellaneous Mesenchymal Neoplasms 1025
Pleural Metastases 1025
Lymphoma 1028
Pathology 1028
Clinical Presentation 1028
Imaging 1028
Radiography 1028
Computed Tomography 1028
Treatment 1029
Suggested Readings 1029
References 1029.e1
15 Mediastinum 1030
75 Pneumomediastinum 1030
Etiology, Prevalence, and Epidemiology 1030
Clinical Presentation 1030
Pathologic Findings and Pathophysiology 1031
Imaging Findings 1032
Radiographic Findings 1032
Computed Tomography 1034
Differential Diagnosis 1036
Imaging Algorithm 1037
Synopsis of Treatment Options 1037
Suggested Reading 1038
References 1038.e1
76 Mediastinitis 1039
Acute Mediastinitis 1039
Etiology, Prevalence, and Epidemiology 1039
Clinical Presentation 1039
Pathologic Findings and Pathophysiology 1040
Imaging Findings 1040
Radiography 1040
Computed Tomography 1040
Imaging Algorithm 1045
Differential Diagnosis 1045
Fibrosing Mediastinitis 1045
Etiology, Prevalence, and Epidemiology 1045
Pathologic Findings and Pathophysiology 1045
Clinical Presentation 1046
Imaging Findings 1046
Radiography 1046
Computed Tomography 1046
Magnetic Resonance Imaging 1047
18F-Fluorodeoxyglucose–Positron Emission Tomography–Computed Tomography 1047
Digital Subtraction Angiography 1047
Differential Diagnosis 1047
Suggested Readings 1050
References 1050.e1
77 Mediastinal Masses* 1051
International Thymic Malignancy Interest Group Definition of Mediastinal Compartments 1051
Prevascular Compartment 1051
Visceral Compartment 1051
Paravertebral Compartment 1051
Imaging of Mediastinal Masses 1052
General Considerations 1052
Radiography 1052
Computed Tomography 1052
Magnetic Resonance Imaging 1052
Fluorodeoxyglucose–Positron Emission Tomography–Computed Tomography 1054
Localization of Mediastinal Masses 1054
Imaging of the Prevascular Compartment 1054
Thymic Epithelial Neoplasms 1054
Thymoma 1054
Thymic Carcinoma and Thymic Neuroendocrine Neoplasms 1055
Fat-Containing Masses 1055
Mature Teratoma 1055
Thymolipoma 1056
Lipoma and Liposarcoma 1056
Thymic Hyperplasia 1057
Cystic Lesions 1057
Thymic Cysts 1057
Mature Teratoma 1057
Other Cystic Lesions 1057
Lymphoma 1058
Nonteratomatous Germ Cell Neoplasms 1060
Thyroid and Parathyroid Lesions 1060
Thyroid Goiter 1060
Parathyroid Adenoma 1060
Imaging of the Visceral Compartment 1060
Foregut Duplication Cysts 1060
Esopohageal Cancer and Other Masses 1061
Enhancing Lesions 1062
Imaging of the Paravertebral Compartment 1065
Neurogenic Neoplasms 1065
Spinal Infections 1066
Cystic Lesions 1067
Intrathoracic Meningocele 1067
Neurenteric Cyst 1068
Other Cystic Lesions 1068
Extramedullary Hematopoiesis 1068
Conclusions 1068
Suggested Readings 1069
References 1069.e1
16 Diaphragm and Chest Wall 1070
78 Diaphragm* 1070
Abnormalities of Diaphragmatic Motion: Diaphragmatic Paralysis, Weakness, and Eventration 1070
Etiology, Prevalence, and Epidemiology 1070
Clinical Presentation 1070
Manifestations of Diaphragm Dysfunction 1070
Radiography and Fluoroscopy 1070
Performing the Fluoroscopic Sniff Testa 1071
Interpreting the Fluoroscopic Sniff Testa 1072
Computed Tomography 1073
Magnetic Resonance Imaging 1073
Ultrasonography 1073
Treatment 1074
Diaphragmatic Hernias 1074
Etiology, Prevalence, and Epidemiology 1074
Clinical Presentation 1075
Manifestations of Diaphragmatic Hernia 1076
Radiography 1076
Computed Tomography 1077
Magnetic Resonance Imaging 1084
Neoplasms of the Diaphragm 1084
Etiology, Prevalence, and Epidemiology 1084
Clinical Presentation 1087
Manifestations of Neoplasms 1087
Radiography 1087
Computed Tomography 1087
Suggested Readings 1087
References 1087.e1
79 Chest Wall 1088
Normal Variants, Congenital Diseases, and Chest Wall Deformities 1088
Poland Syndrome 1088
Pectus Excavatum 1089
Pectus Carinatum 1089
Kyphoscoliosis 1089
Blunt Chest Trauma 1090
Inflammatory and Infectious Diseases 1090
SAPHO Syndrome 1091
Paget Disease 1091
Chest Wall Tumors 1091
Benign Bone Tumors 1095
Fibrous Dysplasia 1095
Osteochondroma 1097
Chondromyxoid Fibroma 1098
Malignant Bone Tumors 1098
Chondrosarcoma 1098
Osteosarcoma 1099
Primitive Neuroectodermal Tumors 1100
Solitary and Multiple Myeloma 1101
Primary Musculoskeletal Lymphoma 1101
Bone Metastases 1102
Benign Soft Tissue Tumors 1103
Elastofibroma Dorsi 1104
Musculoskeletal Fibromatoses 1104
Soft Tissue Sarcomas 1105
Suggested Readings 1107
References 1107.e1
Index 1108
A 1108
B 1110
C 1111
D 1114
E 1115
F 1116
G 1116
H 1117
I 1118
J 1119
K 1119
L 1119
M 1121
N 1123
O 1124
P 1124
Q 1128
R 1128
S 1130
T 1131
U 1133
V 1133
W 1133
Y 1133
Z 1133
Inside Back Cover ibc1